octapharma
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
DISCLOSURES
Montegaard: Pharmacyclics: Consultancy; Janssen: Consultancy. Jacobson:Kite, a Gilead Company: Consultancy, Honoraria…
Factor VIII (FVIII) is indicated for the prevention or treatment of bleeding in patients with hemophilia A. FVIII product…
Direct oral anticoagulant (DOAC) use is increasing worldwide. However, if not taken or prescribed correctly, DOACs have serious…
Abstract We present 25-year experience with inhibitors in previously untreated patients (PUPs) with severe hemophilia A in…
Among adults undergoing non‐cardiac surgery who are at risk of a myocardial infarction, a long‐standing question has been whether…
Patients with haemophilia A (and their physicians) may be reluctant to switch factor VIII (FVIII) concentrates, often due to…
Introduction: Antiepileptic drug (AED) teratogenicity is suspected to be the main cause of impaired development in children of…
Emergency stroke care has become a natural part of the emerging discipline of neurocritical care and demands close cooperation…
Summary. On‐demand therapy with recombinant activated factor VII (rFVIIa) can provide effective haemostasis for spontaneous…
OBJECTIVE
TNF receptor 1-associated periodic syndrome (TRAPS) is a rare disease belonging to the heterogeneous group of…